{"id":"W2808046551","doi":"10.1016/j.annepidem.2018.06.005","title":"The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis–to-need ratio in the fourth quarter of 2017, United States","year":2018,"lang":"en","type":"article","venue":"Annals of Epidemiology","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":427,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Center for Advancing Translational Sciences; National Institute of Mental Health","keywords":"Medicine; Pre-exposure prophylaxis; Emtricitabine; Medical prescription; Epidemiology; Human immunodeficiency virus (HIV); Demography; Quarter (Canadian coin); Tenofovir; Pediatrics; Men who have sex with men; Family medicine; Internal medicine; Antiretroviral therapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08484500390149381,"score_gpt":0.3947155100555875,"score_spread":0.3098705061540937,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}